Email updates

Keep up to date with the latest news and content from Genome Biology and BioMed Central.

Opinion

Is 'big biology' a commercial enterprise?

Mark Swindells

Author Affiliations

Inpharmatica Ltd, 60 Charlotte Street, London W1T 2NU, UK

Genome Biology 2002, 3:comment2004-comment2004.4  doi:10.1186/gb-2002-3-4-comment2004

Published: 26 March 2002

Abstract

Big projects in biology - such as the human genome project and a number of related and ensuing enterprises - require big funding. A new tradition is growing in which some types of basic research take place within commercial organizations. This article reviews some of the reasons for this and some of the key players, in the USA, Europe and Japan, and highlights some issues to be considered when deciding whether particular research belongs in a company rather than an academic setting.